Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03341481
Other study ID # FEMA/01/2014
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2014
Est. completion date November 2015

Study information

Verified date November 2017
Source Medical University of Warsaw
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Femaltiker is a food for special medical purposes with a unique composition. Because beer, but not ethanol, has been reported in a number of studies to stimulate prolactin levels and breastmilk production, polysaccharide from barley was chosen as a potential galactogogue. To verify our assumption, a randomized, double blinded research with placebo was performed. The study was conducted according to good clinical practice and 10% of output data was audited by the outside monitor. The research was conducted from 14 April 2014 to 7 October 2015 in two NICUs with consent of the ethics committee on Medical Warsaw University.


Description:

The traget population consisted of volunteers women who delivered infants at < 37 weeks gestation. Criteria of exclusion were: hypothyroidism and diabetes type I or II diagnosed and treated before pregnancy.

The schedule of the study included three visits with in certain point time during two weeks postpartum. During the study patients had taken twice a day product or placebo, respectively. The protocol of the study included :

- Three consecutive blood collections for examination of prolactin level on every visit (10 min beforeBlood examination of prolactin level in triplet on every visit (10 min before breastfeeding session, 10 min after beginning of breastfeeding and 10 min. after finishing of breastfeeding.)

- Filling pumping log to control variation in the milk yield and efficacy of lactation.

- Measurement of the volume of milk producing before blood examination (directly in case of pumping by the mother or indirectly based on weight of the baby before and after feeding)

- Interview with lactation consultant concerning patient's self-estimation of lactation efficacy Data collection was done using the CRF in the paper form which were then put tto the database in ExcelDocuments.


Recruitment information / eligibility

Status Completed
Enrollment 109
Est. completion date November 2015
Est. primary completion date October 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- mothers of preterm infants (born before 37 completed weeks of pregnancy)

Exclusion Criteria:

- hypothyroidism

- diabetes type I or II diagnosed and treated before pregnancy

- participating in other study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Femaltiker
Patient had taken twice a day the product
Placebo
Patient had taken twice a day the placebo

Locations

Country Name City State
Poland Laboratory of Human Milk and Lactation Research at Regional Human Milk Bank in Holy Family Hospital Warsaw
Poland Mother and Child Health Center of Warsaw Medical University Warsaw
Poland Warsaw Medical University - Clinic of Neonatology Warsaw
Poland Warsaw Medical University Hospital Warsaw

Sponsors (4)

Lead Sponsor Collaborator
Medical University of Warsaw Human Milk Bank Foundation, Nutropharma LLC, University Health Center of Woman and Child, Medical University of Warsaw

Country where clinical trial is conducted

Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary The volume of milk produced by study participants Measurement of the volume of expressed milk two weeks after delivery
Primary Level of serum prolactin Three consecutive blood collections for prolactin level two weeks after delivery
See also
  Status Clinical Trial Phase
Completed NCT04756089 - Stimulation Therapy for Inducing Mothers N/A
Completed NCT06111378 - Effect of OMEGA 3 Fatty Acids on Lactation Period